Feasibility & Effectiveness of Augmented Reality Assistance System for

Status Recruiting

Clinical Trial Summary

Pancreatic cancer necessitates surgical resection for complete tumor eradication, serving as the primary curative approach. However, pancreatic surgery is still challenging due to the organ's retroperitoneal anatomy and proximity to vital vascular systems. Thus, precise preparation and dissection of peripancreatic vessels are crucial during pancreatic surgery to reduce perioperative complications and improve oncological outcomes. The integration of preoperative computed tomography-derived reconstructed images, along with augmenting the resulting 3D model during surgical procedures, holds significant potential in this context. Augmented reality-assistance systems (ARAS) have seen use in various surgical fields, including orthopedic, plastic, and neurosurgery. Nevertheless, the application of ARAS in abdominal surgery has faced challenges related to organ shifting and deformities. The retroperitoneal nature of the pancreas, characterized by minimal intraoperative organ shifts and deformations, makes pancreatic surgery a promising candidate for ARAS. Despite this, there is a limited number of studies exploring the impact of ARAS during pancreatic surgery. Notably, existing investigations have primarily utilized augmented reality technology with 2D-display-based modalities. This prospective study aims to fill this gap by examining the usability, feasibility, and effectiveness of wearable ARAS during pancreatic surgery. By leveraging advanced technology seamlessly integrated into the surgical workflow, this research seeks to provide valuable insights into the practical application of ARAS, potentially enhancing the precision and outcomes of pancreatic surgery. The preliminary findings of this study will also be submitted for publication in a peer-reviewed journal.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06208579
Study type	Observational
Source	Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie
Contact	Gregor A. Stavrou, MD
Phone	0049681963 2441
Email	gstavrou@klinikum-saarbruecken.de
Status	Recruiting
Phase
Start date	September 11, 2023
Completion date	May 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00414908` - A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy	Phase 3
Completed	`NCT00559364` - Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea	Phase 3
Active, not recruiting	`NCT04431076` - Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Recruiting	`NCT05297136` - Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy	N/A
Not yet recruiting	`NCT05737875` - Distal Pancreatectomy Pancreatic Fistula Risk Prediction Model Validation Study
Completed	`NCT03060408` - Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy	N/A
Recruiting	`NCT02230436` - Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial	N/A
Completed	`NCT02509910` - Implementation of a GDT Algorithm for Major Surgery Patients	N/A
Completed	`NCT01929902` - Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
Terminated	`NCT02617979` - Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement	N/A
Recruiting	`NCT06126601` - Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Completed	`NCT02623803` - Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies	Phase 4
Terminated	`NCT02649023` - Deep Venous Thrombosis After Hepatobiliopancreatic Surgery
Completed	`NCT02814812` - Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery	N/A
Active, not recruiting	`NCT04423731` - Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Recruiting	`NCT05856474` - Management of Traumatic Pancreas Transection
Not yet recruiting	`NCT05992857` - Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty	N/A
Completed	`NCT01950845` - Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial	N/A
Not yet recruiting	`NCT04850430` - Gastric Venous Reconstruction After Total Pancreatectomy	N/A
Not yet recruiting	`NCT05722548` - Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Feasibility and Effectiveness of Augmented Reality Assistance System for Pancreatic Surgery — ARAS-P

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms